Sphera Funds Management Ltd. Sutro Biopharma, Inc. Transaction History

Sphera Funds Management Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $2.19 Million - $4.31 Million	-281,702 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $187,002 - $308,784	-13,123 Reduced 4.45%	281,702 $4.19 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $1.89 Million - $2.57 Million	93,225 Added 46.24%	294,825 $6.71 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $2.05 Million - $4.83 Million	201,600 New	201,600 $4.38 Million
Q4 2019 Feb 13, 2020	SELL	$8.15 - $11.39 $3.44 Million - $4.81 Million	-422,589 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$7.91 - $11.76 $184,303 - $274,008	-23,300 Reduced 5.23%	422,589 $3.84 Million
Q2 2019 Aug 14, 2019	BUY	$9.69 - $12.23 $77,520 - $97,840	8,000 Added 1.83%	445,889 $0
Q1 2019 May 15, 2019	BUY	$8.8 - $11.87 $264,000 - $356,100	30,000 Added 7.35%	437,889 $4.99 Million
Q4 2018 Feb 14, 2019	BUY	$8.69 - $14.85 $1.15 Million - $1.97 Million	132,889 Added 48.32%	407,889 $3.68 Million
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $4.13 Million - $4.18 Million	275,000 New	275,000 $4.13 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $98.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.